La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
RMD Aperçu des actions
ResMed Inc. développe, fabrique, distribue et commercialise des dispositifs médicaux et des applications logicielles basées sur le cloud pour les marchés de la santé.
| Score flocon de neige | |
|---|---|
| Évaluation | 5/6 |
| Croissance future | 2/6 |
| Performances passées | 5/6 |
| Santé financière | 6/6 |
| Dividendes | 4/6 |
Community Narratives
Narratives bring a range of perspectives from our community.
Revolutionizing Sleep Health, Wearables, Digital Innovation, And Global Expansion Propel Growth
ResMed Inc. Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$231.30 |
| Plus haut sur 52 semaines | US$231.50 |
| Plus bas sur 52 semaines | US$132.24 |
| Bêta | 0.66 |
| 1Variation sur 1 mois | 13.86% |
| Variation sur 3 mois | 5.96% |
| Variation sur 1 an | 39.43% |
| 3Variation sur 3 ans | -19.08% |
| Variation sur 5 ans | 71.18% |
| Évolution depuis l'introduction en bourse | 34,326.05% |
Nouvelles et mises à jour récentes
Recent updates
ResMed (NYSE:RMD) Is Increasing Its Dividend To $0.53
Aug 05
Does ResMed (NYSE:RMD) Have A Healthy Balance Sheet?
Jul 29Returns On Capital Are A Standout For ResMed (NYSE:RMD)
Jul 15ResMed: Asymmetrical Value Opportunity With High Prospect Of Re-Rating
Jul 03An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 33% Undervalued
Jul 02ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Apr 30Earnings Beat: ResMed Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 30ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear
Apr 18With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
Mar 22Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future
Mar 10An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 30% Undervalued
Feb 12Why ResMed Is One Of My Top Picks In 2024
Jan 22A First Look At ResMed
Jan 09ResMed Inc.'s (NYSE:RMD) Share Price Could Signal Some Risk
Dec 20Why You Should Care About ResMed's (NYSE:RMD) Strong Returns On Capital
Dec 06Shareholders May Find It Hard To Justify Increasing ResMed Inc.'s (NYSE:RMD) CEO Compensation For Now
Nov 10Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 41%?
Nov 01ResMed: Weight-Loss Drug Worries Provide Buying Opportunity
Oct 28ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity
Sep 12ResMed Has Become A Steal (Rating Upgrade)
Aug 10ResMed's (NYSE:RMD) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 07ResMed (NYSE:RMD) Has Some Way To Go To Become A Multi-Bagger
Jul 30Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Jul 16Compound Your Wealth With ResMed
Jul 04A Look At The Fair Value Of ResMed Inc. (NYSE:RMD)
Jul 02We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt
May 26ResMed (NYSE:RMD) Could Be Struggling To Allocate Capital
Apr 24Here's Why ResMed (NYSE:RMD) Has Caught The Eye Of Investors
Apr 09A Look At The Intrinsic Value Of ResMed Inc. (NYSE:RMD)
Mar 26ResMed goes ex dividend tomorrow
Feb 07ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Feb 06Rendement pour les actionnaires
| RMD | US Medical Equipment | US Marché | |
|---|---|---|---|
| 7D | 7.8% | 3.9% | 4.9% |
| 1Y | 39.4% | 11.2% | 25.6% |
Rendement vs Industrie: RMD exceeded the US Medical Equipment industry which returned 10.3% over the past year.
Rendement vs marché: RMD exceeded the US Market which returned 24.7% over the past year.
Volatilité des prix
| RMD volatility | |
|---|---|
| RMD Average Weekly Movement | 5.5% |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.2% |
Cours de l'action stable: RMD has not had significant price volatility in the past 3 months.
Volatilité au fil du temps: RMD's weekly volatility (5%) has been stable over the past year.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1989 | 9,980 | Mick Farrell | www.resmed.com |
ResMed Inc. développe, fabrique, distribue et commercialise des dispositifs médicaux et des applications logicielles basées sur le cloud pour les marchés de la santé. L'entreprise opère dans deux secteurs, le sommeil et les soins respiratoires, et le logiciel en tant que service. Elle propose divers produits et solutions pour une gamme de troubles respiratoires, notamment ApneaLink Air, un appareil de diagnostic portable qui mesure l'oxymétrie, l'effort respiratoire, le pouls, le flux nasal et les ronflements ; et NightOwl, un appareil de diagnostic portable, connecté au nuage et jetable qui mesure l'IAH en fonction du tonus artériel périphérique dérivé, de l'actigraphie et de l'oxymétrie sur plusieurs nuits.
ResMed Inc. Résumé des fondamentaux
| RMD statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$33.46b |
| Bénéfices(TTM) | US$1.02b |
| Recettes(TTM) | US$4.69b |
33.3x
Ratio P/E7.3x
Ratio P/SLe site RMD est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| RMD compte de résultat (TTM) | |
|---|---|
| Recettes | US$4.69b |
| Coût des recettes | US$2.00b |
| Marge brute | US$2.69b |
| Autres dépenses | US$1.67b |
| Les revenus | US$1.02b |
Derniers bénéfices déclarés
Jun 30, 2024
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | 6.95 |
| Marge brute | 57.38% |
| Marge bénéficiaire nette | 21.79% |
| Ratio dettes/capitaux propres | 14.5% |
Quelles ont été les performances à long terme de RMD?
Voir les performances historiques et les comparaisons